VX-770, a CFTR potentiator, may have a potential clinical benefit in a subgroup of people with cystic fibrosis

Title
VX-770, a CFTR potentiator, may have a potential clinical benefit in a subgroup of people with cystic fibrosis
Authors
Keywords
-
Journal
THORAX
Volume 66, Issue 11, Pages 984-984
Publisher
BMJ
Online
2011-02-17
DOI
10.1136/thx.2011.159491

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now